se gb

Pharmaceuticals

Oncology Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Aprea AB

Infections and Wound Healing Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch
Women's Health Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Dilafor AB

Forendo Pharma Oy (endometriosis)

Endocrinology Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Forendo Pharma Oy (Fispemifene)

Cardiovascular and Hematology Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Modus Therapeutics AB (Sevuparin, SCD)

Ophthalmology Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch
CNS Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

BioArctic Neuroscience AB

Umecrine Cognition AB

Inflammation Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch

Technology

Implants Concept Development Prototype Development Product Sales

Promimic AB

OssDsign AB

Diagnostics Concept Development Prototype Development Product Sales
Pharmaceutical Formulation Concept Development Prototype Development Product Sales

Inhalation Sciences Sweden AB

Lipidor AB

Medical Equipment Concept Development Prototype Development Product Sales

Passive/Financial Investments

Pharmaceutical Concept Development Lead Discovery Lead Optimization Preclinical Development Phase I Phase II Phase III Launch


Solid colored area 
= completed phase                  Shaded colored area = ongoing phase

PDF